HR Execs on the Move


 
  • Number of Employees:
  • Annual Revenue:

  • ,

Executives

Name Title Contact Details

Similar Companies

Mercedes-Benz AG

"Love of invention will never end." - Carl Benz Learn more about us as we continue to pioneer the future of driving excellence. Data privacy: mb4.me/provider_privacy Imprint: Mercedes-Benz AG Mercedesstraße 120 D-70372 Stuttgart Deutschland Tel.: +49 7 11 17-0 E-Mail: dialog.mb@mercedes-benz.com Vertreten durch den Vorstand: Ola Källenius (Vorsitzender), Jörg Burzer, Renata Jungo Brüngger, Sabine Kohleisen, Harald Wilhelm, Markus Schäfer, Britta Seeger Vorsitzender des Aufsichtsrats: Martin Brudermüller Handelsregister beim Amtsgericht Stuttgart, Nr. HRB 762873 Umsatzsteueridentifikationsnummer: DE321281763

Revelyst

A collective of category-defining maker brands redefining what is humanly possible in the outdoors.

Global Synergizers

Global Synergizers is a social impact consulting firm that collaborates with corporates, social product innovators and social organisations to enable collective impact. Our programs are aligned with UN SDGs and address issues at the local level to create a systemic effect. If you would like to collaborate with us, write to us on info@globalsynergizers.com.

People of Color Network

At POCN, we seek to support the careers and clinical practices of NPs and PAs - Advanced Clinicians by partnering with life science companies who recognize their critical role on the front lines of healthcare. We are the largest network of Advanced Clinicians in the U.S. and strive to support and enable success for them at every turn. POCN provides Advanced Clinicians with an opportunity engine to grow their careers, earn valuable financial incentives, and increase their clinical knowledge and practice productivity. Recognizing the vital relationship between NPs, PAs, and the broader healthcare and life sciences industries, POCN specializes in developing peer–validated programs that include engaging live and virtual events, helpful patient education resources, incentivized market research programs, clinical reference and prescribing tools, promoted speaking opportunities, as well as CME and continuous learning modules on a variety of disease states and therapies.